beta-Nicotinamide mononucleotide, reduced form (disodium), CAS [[108347-85-9]]

Produktübersicht

• Artikelname: beta-Nicotinamide mononucleotide, reduced form (disodium), CAS [[108347-85-9]]
• Artikelnummer: MCE-HY-W615108B
• Hersteller Artikelnummer: HY-W615108B
• Alternativnummer: MCE-HY-W615108B-5MG,MCE-HY-W615108B-10MG,MCE-HY-W615108B-25MG,MCE-HY-W615108B-100MG,MCE-HY-W615108B-1MG,MCE-HY-W615108B-50MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: NMNH, reduced form (disodium)

Produktbeschreibung

beta-Nicotinamide mononucleotide, reduced form disodium (beta-NMN) is the oxidized form of NAD+ precursor and is a NAD+ enhancer. beta-Nicotinamide mononucleotide, reduced form disodium can be reduced to dihydronicotinamide mononucleotide (NMNH). NMNH inhibits gl

Produkteigenschaften

• Molekulargewicht: 380.20
• Reinheit: 98
• CAS Nummer: [108347-85-9]
• Formel: C11H15N2Na2O8P
• Target-Kategorie: Endogenous Metabolite

Anwendungsbeschreibung

• Anwendungsbeschreibung: Enzyme